ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
AK4 | Adenylate kinase 4 | Enzymes Mitochondrial proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ASS1 | Argininosuccinate synthase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
BAG2 | BCL2-associated athanogene 2 | Plasma proteins
| | | | | Tissue enhanced |
BTK | Bruton agammaglobulinemia tyrosine kinase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
CASC5 | Cancer susceptibility candidate 5 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Tissue enhanced |
CAV1 | Caveolin 1, caveolae protein, 22kDa | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CBS | Cystathionine-beta-synthase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
CDC25C | Cell division cycle 25C | Cancer-related genes Enzymes
| | | | | Tissue enhanced |
CDH2 | Cadherin 2, type 1, N-cadherin (neuronal) | CD markers Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CENPF | Centromere protein F, 350/400kDa | Cancer-related genes Plasma proteins
| | | | | Tissue enhanced |
COL4A2 | Collagen, type IV, alpha 2 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CSTA | Cystatin A (stefin A) | Cancer-related genes Disease related genes Plasma proteins
| | | | | Tissue enhanced |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
FOSL1 | FOS-like antigen 1 | Cancer-related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
GPRC5A | G protein-coupled receptor, family C, group 5, member A | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
IKZF3 | IKAROS family zinc finger 3 (Aiolos) | Transcription factors
| | | | | Tissue enhanced |
IRF8 | Interferon regulatory factor 8 | Disease related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
KYNU | Kynureninase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
LPCAT2 | Lysophosphatidylcholine acyltransferase 2 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
MAP1B | Microtubule-associated protein 1B | Plasma proteins
| | | | | Tissue enhanced |
MORC4 | MORC family CW-type zinc finger 4 | Cancer-related genes
| | | | | Tissue enhanced |
MUC1 | Mucin 1, cell surface associated | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
NCAM1 | Neural cell adhesion molecule 1 | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
NCS1 | Neuronal calcium sensor 1 | | | | | | Tissue enhanced |
NES | Nestin | Plasma proteins
| | | | | Tissue enhanced |
NQO1 | NAD(P)H dehydrogenase, quinone 1 | Cancer-related genes Enzymes
| | | | | Tissue enhanced |
OXCT1 | 3-oxoacid CoA transferase 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
PEG10 | Paternally expressed 10 | | | | | | Tissue enhanced |
PKP3 | Plakophilin 3 | Plasma proteins
| | | | | Tissue enhanced |
PODXL | Podocalyxin-like | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
RIPK2 | Receptor-interacting serine-threonine kinase 2 | Cytoskeleton related proteins Enzymes
| | | | | Tissue enhanced |
S100A14 | S100 calcium binding protein A14 | Plasma proteins
| | | | | Tissue enhanced |
SLC2A1 | Solute carrier family 2 (facilitated glucose transporter), member 1 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
TEAD4 | TEA domain family member 4 | Transcription factors
| | | | | Tissue enhanced |
TFAP2A | Transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) | Disease related genes Transcription factors
| | | | | Tissue enhanced |
TFAP2C | Transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma) | Transcription factors
| | | | | Tissue enhanced |
TOP2A | Topoisomerase (DNA) II alpha 170kDa | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Tissue enhanced |